European Union · Record · QUESTION_WRITTEN_PRIORITY
P-10-2025-001695
Role of the European Medicines Agency (EMA) in the approval process of COVID-19 vaccines, inspections and controls of good clinical practice
Introduced
28 April 2025
Last action
—
Status
answered
Sponsors
—
Subjects
Discovery layer
Source updated
23 June 2025
Records
Official record P-10-2025-001695 from European Union at European Parliament. Dated 28 April 2025. Status: answered.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
5 official files
EMA’s role in COVID-19 vaccine approval procedures, inspections and good clinical practice checks
This file cannot be previewed here. Use View or Download.
EMA’s role in COVID-19 vaccine approval procedures, inspections and good clinical practice checks
QUESTION_WRITTEN_PRIORITY · EN · 5 May 2025
EMA’s role in COVID-19 vaccine approval procedures, inspections and good clinical practice checks
QUESTION_WRITTEN_PRIORITY · EN · 5 May 2025
Answer
QUESTION_WRITTEN_ANSWER · 23 June 2025
Rolle der Europäischen Arzneimittel-Agentur (EMA) bei Zulassungsverfahren der COVID-19-Impfstoffe, Inspektionen und Kontrollen der guten klinischen Praxis
QUESTION_WRITTEN_PRIORITY · DE · 5 May 2025
Rolle der Europäischen Arzneimittel-Agentur (EMA) bei Zulassungsverfahren der COVID-19-Impfstoffe, Inspektionen und Kontrollen der guten klinischen Praxis
QUESTION_WRITTEN_PRIORITY · DE · 5 May 2025
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.